John T. Schiller
1984–2025 年に発表
- 177
- 論文数
- 32,414
- 被引用数
- 110
- h 指数
- 171
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine64.7%
- Biochemistry, Genetics and Molecular Biology16.2%
- Immunology and Microbiology12.3%
- Agricultural and Biological Sciences2.3%
- Environmental Science1.3%
- Social Sciences0.5%
- その他2.7%
トピック
- Cervical Cancer and HPV Research15.6%
- Head and Neck Cancer Studies4.6%
- Immunotherapy and Immune Responses4.4%
- Hepatitis B Virus Studies4.1%
- Virus-based gene therapy research3.9%
- Genital Health and Disease2.6%
- その他64.8%
共著者
- Douglas R. Lowy100
- Allan Hildesheim34
- Carolina Porras27
- Rolando Herrero27
- Aimée R. Kreimer25
- Mark Schiffman25
- Patricia M. Day25
- Richard B.S. Roden22
- Cynthia D. Thompson21
- Ana Cecilia Rodríguez20
- Paula González20
- John Schussler18
- Lígia A. Pinto18
- Joakim Dillner17
- Reinhard Kirnbauer17
- Troy J. Kemp16
- Sholom Wacholder15
- Wim Quint15
- Bernal Cortés14
- Christopher B. Buck12
- Joshua N. Sampson12
- N L Hubbert12
- Mark E. Sherman11
- Rhonda C. Kines11
全論文
- Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial
著者: Aimée R. Kreimer, Joshua N. Sampson, Carolina Porras, John T. Schiller, Troy J. Kemp, Rolando Herrero, Sarah Wagner, Joseph F. Boland, John Schussler, Douglas R. Lowy, Stephen Chanock, David A. Roberson, Mónica S. Sierra, Sabrina H. Tsang, Mark Schiffman, Ana Cecilia Rodríguez, Bernal Cortés, Mitchell H. Gail, Allan Hildesheim, Paula González, Lígia A. Pinto, for the Costa Rica HPV Vaccine Trial (CVT) Group - JNCI Journal of the National Cancer Institute 2020 被引用: 205
- A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
著者: John T. Schiller, Xavier Castellsagué, Suzanne M. Garland - Vaccine 2012 被引用: 742
- Human Papillomavirus Vaccines
著者: Lauri E. Markowitz, John T. Schiller - The Journal of Infectious Diseases 2021 被引用: 164
- Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
著者: Tara Berman, John T. Schiller - Cancer 2017 被引用: 399
- Explanations for the high potency of HPV prophylactic vaccines
著者: John T. Schiller, D R Lowy - Vaccine 2018 被引用: 226
- An Introduction to Virus Infections and Human Cancer
著者: John T. Schiller, Douglas R. Lowy - Recent results in cancer research/Recent Results in Cancer Research 2020 被引用: 133
- Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial
著者: Kathy Baisley, Troy J. Kemp, Aimée R. Kreimer, Partha Basu, John Changalucha, Allan Hildesheim, Carolina Porras, Hilary Whitworth, Rolando Herrero, Charles Lacey, John T. Schiller, Eric Lucas, Paul Mutani, Joakim Dillner, Jackton Indangasi, Richard Muwonge, Richard Hayes, Lígia A. Pinto, Deborah Watson‐Jones - The Lancet Global Health 2022 被引用: 69
- Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
著者: Carolina Porras, Sabrina H. Tsang, Rolando Herrero, Diego Guillén, Teresa M. Darragh, Mark H. Stoler, Allan Hildesheim, Sarah Wagner, Joseph F. Boland, Douglas R. Lowy, John T. Schiller, Mark Schiffman, John Schussler, Mitchell H. Gail, Wim Quint, Rebeca Ocampo, Jorge Morales, Ana Cecilia Rodríguez, Shangying Hu, Joshua N. Sampson, Aimée R. Kreimer, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2020 被引用: 130
- Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial
著者: Jaimie Z. Shing, Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N. Sampson, John Schussler, John T. Schiller, Douglas R. Lowy, Mónica S. Sierra, Loretto J Carvajal, Aimée R. Kreimer, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Sholom Wacholder, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2022 被引用: 52
- Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047
著者: Meredith S. Shiels, Stanley Lipkowitz, Nicole G. Campos, Mark Schiffman, John T. Schiller, Neal D. Freedman, Amy Berrington de González - Cancer Discovery 2023 被引用: 42
- Arrangement of L2 within the Papillomavirus Capsid
著者: Christopher B. Buck, Naiqian Cheng, Cynthia D. Thompson, Douglas R. Lowy, Alasdair C. Steven, John T. Schiller, Benes L. Trus - Journal of Virology 2008 被引用: 355
- Cancer vaccines
著者: John T. Schiller, Douglas R. Lowy, Ian H. Frazer, Olivera J. Finn, Eduardo Vilar, H. Kim Lyerly, Sacha Gnjatic, Neeha Zaidi, Patrick A. Ott, Vinod P. Balachandran, Pierre‐Yves Dietrich, Denis Migliorini, Robert H. Vonderheide, Susan M. Domchek - Cancer Cell 2022 被引用: 42
- A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates
著者: Alexandra Fowler, Koen K. A. Van Rompay, Maureen Sampson, Javier Leo, Jennifer Watanabe, Jodie L. Usachenko, Ramya Immareddy, Debbie M. Lovato, John T. Schiller, Alan T. Remaley, Bryce Chackerian - npj Vaccines 2023 被引用: 29
- Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.
著者: Reinhard Kirnbauer, Frank P. Booy, N. Cheng, Douglas R. Lowy, John T. Schiller - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 被引用: 1,111
- Comprehensive Control of Human Papillomavirus Infections and Related Diseases
著者: F. Xavier Bosch, Thomas R. Broker, David Forman, Anna‐Barbara Moscicki, Maura L. Gillison, John Doorbar, Peter L. Stern, Margaret Stanley, Marc Arbyn, Mario Poljak, Jack Cuzick, Philip E. Castle, John T. Schiller, Lauri E. Markowitz, William A. Fisher, Karen Canfell, Lynette Denny, Eduardo L. Franco, Marc Steben, Mark Kane, Mark Schiffman, Chris J.L.M. Meijer, Rengaswamy Sankaranarayanan, Xavier Castellsagué, Jane J. Kim, María Brotons, Laia Alemany, G. Albero, Mireia Díaz, Silvia de Sanjosé - Vaccine 2013 被引用: 440
- Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial
著者: Sabrina H. Tsang, Joshua N. Sampson, John Schussler, Carolina Porras, Sarah Wagner, Joseph F. Boland, Bernal Cortés, Douglas R. Lowy, John T. Schiller, Mark Schiffman, Troy J. Kemp, Ana Cecilia Rodríguez, Wim Quint, Mitchell H. Gail, Lígia A. Pinto, Paula González, Allan Hildesheim, Aimée R. Kreimer, Rolando Herrero, for the Costa Rica HPV Vaccine Trial (CVT) Group - JNCI Journal of the National Cancer Institute 2020 被引用: 88
- Bacterial superglue enables easy development of efficient virus-like particle based vaccines
著者: Susan Thrane, Christoph M. Janitzek, Sungwa Matondo, Mafalda Resende, Tobias Gustavsson, Willem A. de Jongh, Stine B. Clemmensen, Will Roeffen, Marga van de Vegte‐Bolmer, Geert Jan van Gemert, Robert W. Sauerwein, John T. Schiller, Morten A. Nielsen, Thor G. Theander, Ali Salanti, Adam F. Sander - Journal of Nanobiotechnology 2016 被引用: 208
- Understanding and learning from the success of prophylactic human papillomavirus vaccines
著者: John T. Schiller, Douglas R. Lowy - Nature Reviews Microbiology 2012 被引用: 287
- A cholesterol-lowering VLP vaccine that targets PCSK9
著者: Erin Crossey, Marcelo Amar, Maureen Sampson, Julianne Peabody, John T. Schiller, Bryce Chackerian, Alan T. Remaley - Vaccine 2015 被引用: 149
- Carrageenan Is a Potent Inhibitor of Papillomavirus Infection
著者: Christopher B. Buck, Cynthia D. Thompson, Jeffrey N. Roberts, Martin Müller, Douglas R. Lowy, John T. Schiller - PLoS Pathogens 2006 被引用: 499
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
著者: Aimée R. Kreimer, Ana Cecilia Rodríguez, Allan Hildesheim, Rolando Herrero, Carolina Porras, Mark Schiffman, Paula González, Diane Solomon, Silvia Jiménez, John T. Schiller, Douglas R. Lowy, Wim Quint, Mark E. Sherman, John Schussler, Sholom Wacholder, for the CVT Vaccine Group - JNCI Journal of the National Cancer Institute 2011 被引用: 326
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
著者: Aimée R. Kreimer, Rolando Herrero, Joshua N. Sampson, Carolina Porras, Douglas R. Lowy, John T. Schiller, Mark Schiffman, Ana Cecilia Rodríguez, Stephen J. Chanock, Silvia Jiménez, John Schussler, Mitchell H. Gail, Mahboobeh Safaeian, Troy J. Kemp, Bernal Cortés, Lígia A. Pinto, Allan Hildesheim, Paula González - Vaccine 2018 被引用: 151
- molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history
著者: Mykhaylo Usyk, Nicolas F. Schlecht, Sarah Pickering, LaShanda Williams, Christopher C. Sollecito, Ana Gradíssimo, Carolina Porras, Mahboobeh Safaeian, Lígia A. Pinto, Rolando Herrero, Howard D. Strickler, V. Shankar, Anne Nucci‐Sack, Ángela Díaz, Costa Rica HPV Vaccine Trial (CVT) Group, Bernal Cortés, Paula González, Silvia E. Jiménez, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Sholom Wacholder, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler, Robert D. Burk - Nature Communications 2022 被引用: 64
- Public health opportunities resulting from sufficient HPV vaccine supply and a single-dose vaccination schedule
著者: Aimée R. Kreimer, Tania Cernuschi, Helen Rees, Julia Brotherton, Carolina Porras, John T. Schiller - JNCI Journal of the National Cancer Institute 2022 被引用: 25
